-
Mashup Score: 0FDA Approves Expanded Indication for Merck’s Pneumococcal Vaccine for Infants and Children - 2 year(s) ago
The company’s 15-valent conjugate shot becomes the first one that is approved in nearly a decade.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0FDA Approves Expanded Indication for Merck’s Pneumococcal Vaccine for Infants and Children - 2 year(s) ago
The company’s 15-valent conjugate shot becomes the first one that is approved in nearly a decade.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#ICYMI The #FDA approved the #Merck 15-valent conjugate shot for infants through children 17 years old. https://t.co/ZNE5A3yvMw
-
-
Mashup Score: 0The New COVID Antiviral Pills: What You Need to Know - 2 year(s) ago
WEDNESDAY, Dec. 29, 2021 (HealthDay News) — New antiviral pills for COVID-19 recently authorized for emergency use in high-risk people by the U.S. Food and Drug Administration should give doctors an easier means of keeping people out of the hospital.But the initial hype is giving way to reality, as…
Source: Consumer Health News | HealthDayCategories: General Medicine News, Latest HeadlinesTweet-
What you need to know about the new #covid19 anti-viral pill https://t.co/pW0panW4Cm #pfizer #paxlovid #merck #molnupiravir
-
-
Mashup Score: 23
The US Food and Drug Administration (FDA) has issued emergency use authorization to a second oral COVID-19 treatment. Called molnupiravir the new drug is not as effective as Pfizer’s recently approved COVID antiviral pill, and many experts suggest the FDA should never have authorized it in the…
Source: New AtlasCategories: Healthcare Professionals, Latest HeadlinesTweet-
Huh!? #FDA authorization of #Merck #COVID pill called "worst decision in its history" https://t.co/KOb5u6nwc5 @healthnewsch
-
-
Mashup Score: 0
Welcome! You are invited to join a meeting: Evolution in mUC Treatment : Role of Immunotherapies. After registering, you will receive a confirmation email about joining the meeting.
Source: Zoom Video CommunicationsCategories: Latest Headlines, Oncologists1Tweet-
https://t.co/u5eszbTrzu #merck #urinarybladdercancer #Immunotherapy #urothelialcancer https://t.co/gAH87pshOz
-
-
Mashup Score: 1
FDA advisors voted 13-to-10 in favor of authorization given risks and modest benefits.
Source: Ars TechnicaCategories: Healthcare Professionals, Latest HeadlinesTweet-
😔 Womp, womp: Efficacy of #Merck’s Thor-inspired COVID pill crumbles, vexing experts #Covid #Covid19 @JohnNosta https://t.co/5MFmEQqqhn
-
-
Mashup Score: 0
-
“Vaccines are given to a normal individual who is not infected at that point in time, whereas a pill is given to only those who are positive for #Covid,” says Senior Medical Oncologist Dr Anita Ramesh Chandra (@AnitaRamesh12), on #Pfizer’s #Covid pill. https://t.co/kjnGT3ilOd
Read the original tweet here
Source: TwitterCategories: Latest Headlines, Oncologists1Tweet-
https://t.co/32F98iQE6s #covidvaccine #medicaloncologist #covid19 #covidpills #clinicaltrials #pfizer #merck #antiviraldrugforcoronavirus https://t.co/zdkXtDcytN
-
-
Mashup Score: 1FDA advisers narrowly endorse Merck's COVID-19 antiviral pill - 2 year(s) ago
An advisory group for the Food and Drug Administration (FDA) has voted to recommend Merck’s COVID-19 antiviral pill for infected adults at high risk for severe coronavirus illness, hospitalization or death.
Source: TheHillCategories: Healthcare Professionals, Latest HeadlinesTweet-
Narrowly?? #FDA advisers narrowly endorse #Merck’s #Covid19 antiviral pill 💊 @IrmaRaste https://t.co/cmdt52iBOX
-
-
Mashup Score: 12
Merck’s molnupiravir was poised to be the first oral COVID-19 treatment, but updated data shows its efficacy may have been exaggerated.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#Merck’s #molnupiravir was poised to be the first oral #COVID19 treatment, but updated data shows its efficacy may have been exaggerated. https://t.co/ecCWQiBcNy
-
-
Mashup Score: 0Bloomberg - Are you a robot? - 3 year(s) ago
Why did this happen? Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy. Need Help? For inquiries related to this message please contact our support team and provide the reference ID…
Source: www.bloomberg.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
BREAKING: #Pfizer will allow generic-drug manufacturers to produce inexpensive versions of its #Covid19 pill, following a similar move by #Merck https://t.co/qDi7WT8ch2 @business #pharma https://t.co/079QYca4sn
-
The #Merck 15-valent conjugate #vaccine becomes the first one that is #FDA approved in nearly a decade. https://t.co/ZNE5A3gUUY